Showing results (1-10 of 443) with videos related to
Sort By:
Pageof 45
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemiaA Saven, R H Lemon, M Kosty, et al.Leukemia & Lymphoma|July 28, 2016
2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic LeukemiaA Saven, C J Carrera, D A Carson, et al.Blood|August 1, 1992
2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphomaA Saven, C J Carrera, D A Carson, et al.Blood|September 1, 1991
Enzyme replacement therapy for Gaucher diseaseE Beutler, A Kay, A Saven, et al.Medicine|November 1, 1992
Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patientsA Zimran, A Kay, T Gelbart, et al.Cancer|June 15, 1994
Complete hematologic remissions in chronic-phase, Philadelphia-chromosome-positive, chronic myelogenous leukemia after 2-chlorodeoxyadenosineA Saven, L D Piro, R H Lemon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
2-Chlorodeoxyadenosine treatment of low-grade lymphomasA C Kay, A Saven, C J Carrera, et al.Leukemia & Lymphoma|July 28, 2016
2-Chlorodeoxyadenosine (2-CdA): A Potent Chemotherapeutic and Immunosuppressive NucleosideE Beutler, L D Piro, A Saven, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
2-Chlorodeoxyadenosine dose escalation in nonhematologic malignanciesA Saven, H Kawasaki, C J Carrera, et al.Pageof 45